New Experimental Therapy for A.L.S. Approved in Canada

Health
By BY PAM BELLUCK from NYT Health https://ift.tt/fE15Vzn
via IFTTT your-feed-science, Drugs (Pharmaceuticals), Amyotrophic Lateral Sclerosis, Clinical Trials The F.D.A. is also reviewing the treatment, Albrioza, but the agency’s scientists have raised questions about its effectiveness.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda